Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Immunovant Inc shares valued at $318,047 were purchased by GEORGE V MIGAUSKY on May 21 ’25. At $14.58 per share, GEORGE V MIGAUSKY acquired 21,812 shares.
Also, GEORGE V MIGAUSKY purchased 28,188 shares, netting a total of over 410,908 in proceeds.
Before that, Stout Jay S had sold 1,925 shares from its account. In a trade valued at $28,471, the Chief Technology Officer traded Immunovant Inc shares for $14.79 each. Upon closing the transaction, the insider’s holdings decreased to 1,925 shares, worth approximately $2.95 million.
As published in their initiating research note from Jefferies on March 03, 2025, Immunovant Inc [IMVT] has been a Hold and the price target has been revised to $20. Analysts at Wolfe Research downgraded the stock from ‘”an Outperform”‘ to ‘”a Peer perform”‘ outlook in a report released in early January. Earlier on October 09, 2024, Oppenheimer resumed its rating. Their recommendation was “an Outperform” for IMVT stock.
Analyzing IMVT Stock Performance
During the last five days, there has been a drop of approximately -6.00%. Over the course of the year, Immunovant Inc shares have dropped approximately -43.08%. Shares of the company reached a 52-week high of $25.79 on 01/02/25 and a 52-week low of $12.72 on 04/09/25.
Support And Resistance Levels for Immunovant Inc (IMVT)
According to the 24-hour chart, there is a support level at 13.62, which, if violated, would cause prices to drop to 13.14. In the upper region, resistance lies at 14.75. The next price resistance is at 15.40. RSI (Relative Strength Index) is 43.05 on the 14-day chart, showing neutral technical sentiment.
